NEW YORK (GenomeWeb News) – Quest Diagnostics held its first-ever Investor Day last Friday in New York providing a highly detailed view of its refocused strategy aimed at gaining share in the diagnostic testing market and its plans to revive flagging revenues.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.